₃F Etcharry-Bouyx

Key Opinion Leader In [F Etcharry-Bouyx is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (22) [keywords assigned to F Etcharry-Bouyx articles by PubMed, the leading number and the color conveys importance]

₃Humans | ₂Male | ₂Adult | ₁Multiple Sclerosis | ₁Adjuvants, Immunologic | ₁Leukodystrophy, Metachromatic | ₁Age of Onset | ₁Female | ₁Neurologic Examination | ₁Diagnosis, Differential | ₁Middle Aged | ₁Magnetic Resonance Imaging | ₁Interferon-beta | ₁Depression | ₁Delusions | ₁Apraxia, Ideomotor | ₁Apraxias | ₁Delirium | ₁Genes, Dominant | ₁Brain | ₁Pedigree | ₁Phenotype

Other [context-specific ads]

F Etcharry-Bouyx Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; F Etcharry-Bouyx might be a good expert witness on these terms]

₆ifn-beta-1a | ₅case | ₅therapy | ₅leucodystrophy | ₅orthochromatic | ₄report | ₄ms | ₃features | ₃sclerosis | ₃cases | ₃delirium | ₃acute | ₃depression | ₃multiple | ₃psychiatric | ₃delusion | ₃clinicopathological | ₃onset | ₂patient | ₂established | ₂treatment | ₂patients | ₂signs | ₂effects | ₂aged | ₂mri | ₂inherited | ₂dementia | ₂years | ₂dominantly | ₂adult | ₂epilepsy
₄ifn-beta-1a therapy | ₃multiple sclerosis | ₃delirium delusion | ₃delusion depression | ₃acute delirium | ₃orthochromatic leucodystrophy | ₂therapy ms | ₂leucodystrophy clinicopathological | ₂depression ifn-beta-1a | ₂dominantly inherited | ₂therapy multiple | ₂sclerosis case | ₂cases dominantly | ₂case report | ₂onset orthochromatic | ₂aged years | ₂dementia epilepsy | ₂clinicopathological cases | ₂inherited adult | ₂adult onset | ₁psychotic symptoms | ₁mri findings | ₁histopathological features | ₁relapsing-remitting multiple | ₁taking ifn-beta-1a | ₁vulnerability patients | ₁ms developed | ₁main characteristics | ₁flair sequences | ₁ceased treatment | ₁established patient | ₁orthochromatic type
₃delirium delusion depression | ₃acute delirium delusion | ₂ifn-beta-1a therapy ms | ₂clinicopathological cases dominantly | ₂multiple sclerosis case | ₂dominantly inherited adult | ₂therapy multiple sclerosis | ₂leucodystrophy clinicopathological cases | ₂adult onset orthochromatic | ₂ifn-beta-1a therapy multiple | ₂onset orthochromatic leucodystrophy | ₂delusion depression ifn-beta-1a | ₂inherited adult onset | ₂sclerosis case report | ₂cases dominantly inherited | ₂depression ifn-beta-1a therapy | ₁histopathological features | ₁characteristics probably autosomal | ₁dementia epilepsy aged | ₁multiple sclerosis ms | ₁matter mri findings | ₁report adverse effects | ₁adverse effects interferon | ₁ifn treatment common | ₁ifn-beta-1a established therapy | ₁developed acute delirium | ₁side effects debated | ₁type heterogeneous group | ₁recurrent major depressive | ₁known enzyme deficiency | ₁fully established patient | ₁ms developed acute

Authoratory™
•home •community •tutorial •authors •keywords •search •top ranked •login	Update 2008, Q3 Live! Excel CSV XML print ₃F Etcharry-Bouyx << 2001 \| 2003 \| 2006 >> Summary Social Network Interests Funding Articles Comments All Key Opinion Leader In [F Etcharry-Bouyx is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors] no keywords assigned Keywords (22) [keywords assigned to F Etcharry-Bouyx articles by PubMed, the leading number and the color conveys importance] ₃Humans \| ₂Male \| ₂Adult \| ₁Multiple Sclerosis \| ₁Adjuvants, Immunologic \| ₁Leukodystrophy, Metachromatic \| ₁Age of Onset \| ₁Female \| ₁Neurologic Examination \| ₁Diagnosis, Differential \| ₁Middle Aged \| ₁Magnetic Resonance Imaging \| ₁Interferon-beta \| ₁Depression \| ₁Delusions \| ₁Apraxia, Ideomotor \| ₁Apraxias \| ₁Delirium \| ₁Genes, Dominant \| ₁Brain \| ₁Pedigree \| ₁Phenotype Other [context-specific ads] F Etcharry-Bouyx Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; F Etcharry-Bouyx might be a good expert witness on these terms] ₆ifn-beta-1a \| ₅case \| ₅therapy \| ₅leucodystrophy \| ₅orthochromatic \| ₄report \| ₄ms \| ₃features \| ₃sclerosis \| ₃cases \| ₃delirium \| ₃acute \| ₃depression \| ₃multiple \| ₃psychiatric \| ₃delusion \| ₃clinicopathological \| ₃onset \| ₂patient \| ₂established \| ₂treatment \| ₂patients \| ₂signs \| ₂effects \| ₂aged \| ₂mri \| ₂inherited \| ₂dementia \| ₂years \| ₂dominantly \| ₂adult \| ₂epilepsy ₄ifn-beta-1a therapy \| ₃multiple sclerosis \| ₃delirium delusion \| ₃delusion depression \| ₃acute delirium \| ₃orthochromatic leucodystrophy \| ₂therapy ms \| ₂leucodystrophy clinicopathological \| ₂depression ifn-beta-1a \| ₂dominantly inherited \| ₂therapy multiple \| ₂sclerosis case \| ₂cases dominantly \| ₂case report \| ₂onset orthochromatic \| ₂aged years \| ₂dementia epilepsy \| ₂clinicopathological cases \| ₂inherited adult \| ₂adult onset \| ₁psychotic symptoms \| ₁mri findings \| ₁histopathological features \| ₁relapsing-remitting multiple \| ₁taking ifn-beta-1a \| ₁vulnerability patients \| ₁ms developed \| ₁main characteristics \| ₁flair sequences \| ₁ceased treatment \| ₁established patient \| ₁orthochromatic type ₃delirium delusion depression \| ₃acute delirium delusion \| ₂ifn-beta-1a therapy ms \| ₂clinicopathological cases dominantly \| ₂multiple sclerosis case \| ₂dominantly inherited adult \| ₂therapy multiple sclerosis \| ₂leucodystrophy clinicopathological cases \| ₂adult onset orthochromatic \| ₂ifn-beta-1a therapy multiple \| ₂onset orthochromatic leucodystrophy \| ₂delusion depression ifn-beta-1a \| ₂inherited adult onset \| ₂sclerosis case report \| ₂cases dominantly inherited \| ₂depression ifn-beta-1a therapy \| ₁histopathological features \| ₁characteristics probably autosomal \| ₁dementia epilepsy aged \| ₁multiple sclerosis ms \| ₁matter mri findings \| ₁report adverse effects \| ₁adverse effects interferon \| ₁ifn treatment common \| ₁ifn-beta-1a established therapy \| ₁developed acute delirium \| ₁side effects debated \| ₁type heterogeneous group \| ₁recurrent major depressive \| ₁known enzyme deficiency \| ₁fully established patient \| ₁ms developed acute

	Copyright © 2006-2008 Authoratory.com \| All rights reserved \| Terms of use \| Privacy policy The content of this page was generated automatically by a computer program.

3F Etcharry-Bouyx

Key Opinion Leader In [F Etcharry-Bouyx is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

Keywords (22) [keywords assigned to F Etcharry-Bouyx articles by PubMed, the leading number and the color conveys importance]

Other [context-specific ads]

F Etcharry-Bouyx Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; F Etcharry-Bouyx might be a good expert witness on these terms]

₃F Etcharry-Bouyx